Lucid Genomics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.43M

  • Investors
  • 8

Lucid Genomics General Information

Description

Developer of a long-read genome interpretation platform designed to turn sequencing data into actionable clinical answers. The company's technology integrates artificial intelligence for variant prioritization, phenotype matching, karyotyping-like inspection, differential methylation analysis, long-read native processing and end-to-end interpretation, enabling medical geneticists and research centers to identify genetic variants and actionable insights with precision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Donaustraße 44
  • 12043 Berlin
  • Germany
+49 0176
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Decision/Risk Analysis
Biotechnology
Corporate Office
  • Donaustraße 44
  • 12043 Berlin
  • Germany
+49 0176

Lucid Genomics Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lucid Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 02-Sep-2024 $1.43M Completed Generating Revenue
3. Accelerator/Incubator 01-Apr-2024 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2024 $270K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2024 $270K $270K Completed Generating Revenue
To view Lucid Genomics’s complete valuation and funding history, request access »

Lucid Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lucid Genomics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
another.vc Venture Capital Minority
Ascenion Accelerator/Incubator Minority
BIF Partners Venture Capital Minority
Caesar Ventures Venture Capital Minority
Max Planck Förderstiftung Limited Partner Minority
You’re viewing 5 of 8 investors. Get the full list »

Lucid Genomics FAQs

  • When was Lucid Genomics founded?

    Lucid Genomics was founded in 2024.

  • Where is Lucid Genomics headquartered?

    Lucid Genomics is headquartered in Berlin, Germany.

  • What is the size of Lucid Genomics?

    Lucid Genomics has 11 total employees.

  • What industry is Lucid Genomics in?

    Lucid Genomics’s primary industry is Discovery Tools (Healthcare).

  • Is Lucid Genomics a private or public company?

    Lucid Genomics is a Private company.

  • What is Lucid Genomics’s current revenue?

    The current revenue for Lucid Genomics is .

  • How much funding has Lucid Genomics raised over time?

    Lucid Genomics has raised $1.7M.

  • Who are Lucid Genomics’s investors?

    another.vc, Ascenion, BIF Partners, Caesar Ventures, and Max Planck Förderstiftung are 5 of 8 investors who have invested in Lucid Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process